Splenic rupture: an additional complication of thrombolytic therapy.
Summers
James Bradley
JB
D002404:Catheterization; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009730:Nursing Assessment; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000009:adverse effects* / Q000627:therapeutic use; D013161:Splenic Rupture / Q000139:chemically induced* / Q000175:diagnosis; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000451:nursing*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; C087896:reteplase; D010959:Tissue Plasminogen Activator